The NHS is calling on its workforce to protect themselves and their patients this year by taking up their free flu jab. Spearheaded by Ruth May, England’s chief nursing officer, the drive is aiming to help both patients and staff need to take less time off over the busy winter period, as well as making
Sanofi has revealed plans to fly supplies of flu vaccine into the UK if other transport routes are disrupted once the country leaves the EU. Hugo Fry, the managing director of its UK arm, told BBC Radio 5 live’s Wake Up To Money that the flu vaccine was one it was not possible to stockpile. “We prepare
Experts in a new report have noted a worldwide resurgence of measles, with many countries experiencing “severe and protracted” outbreaks last year. The WHO data shows a rise in cases in almost every region of the world, with 30% more cases in 2017 than 2016. Experts say complacency, collapsing health systems and a rise in
The World Health Organisation (WHO) has reported that cases of measles in Europe have hit a record high. Measles is a highly infectious virus that spreads via droplets in coughs and sneezes. Over 41,000 people have been infected in the first six months of 2018, and has led to 37 deaths. Last year there were
UK health experts have identified what they believe is the 10 most important medicines and vaccines launched on the NHS in the past 70 years. The list includes two vaccines which prevent polio and measles, mumps and rubella in addition to medicines that have transformed HIV/AIDS from a death sentence to a manageable condition, immunosuppressants
Boys in England will be vaccinated against the human papilloma virus in line with recent recommendations from the Joint Committee on Vaccination and Immunisation (JCVI). The vaccine will protects men from HPV-related diseases, which include oral, throat, penile and anal cancer. Whilst also helping to reduce the overall number of cervical cancers in women through
A vaccine to immunise people against high levels of cholesterol and the narrowing of the arteries caused by build-up of fatty material (atherosclerosis) may be possible following successful results in mice. Now, a phase I trial in patients has started to see if the findings translate to humans. The study, which is published today in
GlaxoSmithKline’s meningitis B vaccine, Bexsero, has shown to have a dramatic impact on meningitis B cases within the UK, according to a real-world evidence study. Approximately a year ago the world’s first national meningitis B vaccination campaign was launched, after 10 months there have been reported cases of meningitis B drop 50% compared to the
Takeda has initiated a clinical trial testing the potential of the world’s first experimental vaccine for norovirus, which is responsible for nearly three quarters of a billion illnesses and 219,000 deaths each year around the globe. The Phase IIb, double-blind, randomised, placebo-controlled study will be assessing the efficacy of the candidate – via intramuscular administration
